Thursday, May 20, 2021 7:02:22 PM
Now reading all the news. I like that they are trying to get FDA approval and of course this will be a back in forth thing. But I think this will get pushed though.
Something else I noticed, The Chairman of the board/CEO just got 26 Million shares of common stock. For his service to the company. Is anyone worried about this? With the disappointed attempts with the FDA for 12 years. The impact of lawsuits. Never getting listed on Nasdaq and he gets 26 million shares? That is a bit worrisome that he gets that kind of reward for really a lackluster 12 years. We have a product that seems to be good.
I will hold. I will check back again in a few months. But if anyone can tell me how and why we just dumped 26 million shares of common stock for him to do whatever he likes. Thats 10% of the outstanding shares all given to him for really not doing anything.
Recent UEEC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:05:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 09:10:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM